Who
Allan Kirk
Director
Company insider
Files Form 4 as: Director, Eledon Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Oct 2023
- Last trade
- 10 Jan 2026
- Last filed
- 16 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,870 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,430 at $0.00 | filing |
| 2 Oct 2023filed 3 Oct 2023 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $233K150,437 at $1.55 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.